发明名称 |
Treating basal-like genotype cancers |
摘要 |
Provided herein are methods of treating a subject with cancer comprising administering to the subject a death receptor agonist. Also provided herein are methods of screening a breast cancer cell for responsiveness to a DR5 agonist. Further provided herein are antibodies that selectively bind an N-terminal CARD of DDX3, a DDX3 lacking an N-terminal CARD, and an 80 kDa baculovirus TAP repeat (BIR). |
申请公布号 |
US9527915(B2) |
申请公布日期 |
2016.12.27 |
申请号 |
US201012940746 |
申请日期 |
2010.11.05 |
申请人 |
The UAB Research Foundation |
发明人 |
Buchsbaum Donald J.;Zhou Tong;LoBuglio Albert F. |
分类号 |
A61K39/395;G01N33/50;C07K16/28 |
主分类号 |
A61K39/395 |
代理机构 |
Kilpatrick Townsend & Stockton LLP |
代理人 |
Kilpatrick Townsend & Stockton LLP |
主权项 |
1. A method of treating a subject with cancer, the method comprising:
(a) selecting a subject with a breast cancer, wherein the breast cancer is a basal-like genotype cancer and is HER2 non-amplified, and wherein the breast cancer shows reduced levels of DR5/DDX3/cIAP1 complex as compared to a control; and (b) administering to the subject a death receptor agonist, wherein the death receptor agonist is a DR5 agonist. |
地址 |
Birmingham AL US |